CIK 0000897448 · Accelerated filer
AMARIN CORP PLCUK
Sign in to watch- Ticker
- AMRN
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- United Kingdom
- Entity type
- operating
- Phone
- 353 1 6699 020
- Business address
- SPACES SOUTH DOCKLANDS, BLOCK C, 77 SIR JOHN ROGERSON'S QUAY, DUBLIN 2, Ireland
- Former names
- AMARIN CORP PLC\UK, AMARIN PHARMACEUTICALS PLC, ETHICAL HOLDINGS PLC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2020-02-28 | Berg Aaron CHIEF COMMERCIAL OFFICER | Shares withheld for taxes | −1,506 | $14.67 | $22K | 188,905 |
| 2020-02-28 | Berg Aaron CHIEF COMMERCIAL OFFICER | Option exercise · Restricted Stock Units | −1,528 | 27,498 | ||
| 2020-02-28 | Berg Aaron CHIEF COMMERCIAL OFFICER | Option exercise · Restricted Stock Units | −1,528 | 27,498 | ||
| 2020-02-28 | Kalb Michael Wayne SVP and CFO | Option exercise | +1,528 | 83,897 | ||
| 2020-02-28 | Kalb Michael Wayne SVP and CFO | Option exercise | +1,528 | 85,425 | ||
| 2020-02-28 | Kalb Michael Wayne SVP and CFO | Shares withheld for taxes | −1,498 | $14.67 | $22K | 83,927 |
| 2020-02-28 | Kalb Michael Wayne SVP and CFO | Option exercise · Restricted Stock Units | −1,528 | 27,498 | ||
| 2020-02-28 | Kalb Michael Wayne SVP and CFO | Option exercise · Restricted Stock Units | −1,528 | 27,498 | ||
| 2020-02-28 | Ketchum Steven B Chief Scientific Officer | Option exercise | +1,528 | 515,990 | ||
| 2020-02-28 | Ketchum Steven B Chief Scientific Officer | Option exercise | +1,528 | 517,518 | ||
| 2020-02-28 | Ketchum Steven B Chief Scientific Officer | Shares withheld for taxes | −1,506 | $14.67 | $22K | 516,012 |
| 2020-02-28 | Ketchum Steven B Chief Scientific Officer | Option exercise · Restricted Stock Units | −1,528 | 27,498 | ||
| 2020-02-28 | Ketchum Steven B Chief Scientific Officer | Option exercise · Restricted Stock Units | −1,528 | 27,498 | ||
| 2020-02-28 | Kennedy Joseph T General Counsel | Option exercise | +1,806 | 191,701 | ||
| 2020-02-28 | Kennedy Joseph T General Counsel | Option exercise | +1,806 | 193,507 | ||
| 2020-02-28 | Kennedy Joseph T General Counsel | Option exercise · Restricted Stock Units | −1,806 | 32,497 | ||
| 2020-02-28 | Kennedy Joseph T General Counsel | Option exercise · Restricted Stock Units | −1,806 | 32,497 | ||
| 2020-02-28 | THERO JOHN F President and CEO | Option exercise | +6,736 | 2,679,007 | ||
| 2020-02-28 | THERO JOHN F President and CEO | Option exercise | +6,736 | 2,685,743 | ||
| 2020-02-28 | THERO JOHN F President and CEO | Shares withheld for taxes | −5,302 | $14.67 | $78K | 2,680,441 |
Page 55 of 67 · 1,339 trades